It Rather Looks Like The South Australian ePAS Program Is Nearing Some Final Outcome.
These appeared last week:First:SA Health review: EPAS must be overhauled or scrappedAdam Langenberg, Political reporter, The AdvertiserSeptember 26, 2018 6:56pmTHE health system ’s trouble-plagued electronic patient record system will be overhauled or scrapped altogether, after an SA Health review “confirmed” concerns about its operation.Three health experts will determine if issues with the electronic patient administration system (EPAS) can be “addressed adequatel y” after a review found it couldn’t proceed in its current form.SA Health chief executive Chris McGowan said the panel would also consider whether the problems were so significant that EPAS needs to be scrapped entirely.“The independent expert panel will now look at options regarding the futur e of theEPAS roll out and will be consulting with stakeholders on the options,” SA Health chief executive Chris McGowan said.“The expert panel needs to determine if the issues raised with EPAS can be addressedadequately in order for it... This is the initial part of the post - read more by clicking on the title of the article. David.
Shaney L. Barratt, Sarah Mulholland, Khaled Al Jbour, Henry Steer, Markus Gutsche, Noeleen Foley, Rajiv Srivastava, Charles Sharp, Huzaifa I. Adamali
Pei-Li Zhu, Xiu-Qiong Fu, Jun-Kui Li, Anfernee Kai-Wing Tse, Hui Guo, Cheng-Le Yin, Ji-Yao Chou, Ya-Ping Wang, Yu-Xi Liu, Ying-Jie Chen, Muhammad Jahangir Hossen, Yi Zhang, Si-Yuan Pan, Zong-Jie Zhao, Zhi-Ling Yu
Yiming Chen, Yuping Jia, Weiguo Song, Lei Zhang
Jhana O. Hendrickx, Jaana van Gastel, Hanne Leysen, Paula Santos-Otte, Richard T. Premont, Bronwen Martin, Stuart Maudsley
Publication date: Available online 17 December 2018Source: Asian Journal of Pharmaceutical SciencesAuthor(s): Lipeng Qiu, Lu Ge, Miaomiao Long, Jing Mao, Kamel S. Ahmed, Xiaotian Shan, Huijie Zhang, Li Qin, Guozhong Lv, Jinghua ChenAbstractHeparosan is a natural precursor of heparin biosynthesis in mammals. It is stable in blood circulation but can be degraded in lysosomes, showing good biocompatibility and long circulation features. So heparosan can be designed as anticancer drug carriers to increase tumor selectivity and improve the therapeutic effect. A novel redox-sensitive heparosan-cystamine-vitamin E succinate (KSV)...
Conclusion: Our findings are the first report of co-segregation of the mutation in 6 family members, supporting its pathogenic role.Cardiology 2018;141:150 –155
Kelvin M. Jones, Balasubramanyam Karanam, Jacqueline Jones-Triche, Maninder Sandey, Henry J. Henderson, Rajeev S. Samant, Samuel Temesgen, Clayton Yates, Deepa Bedi
Marie-France Penet, Balaji Krishnamachary, Flonn é B. Wildes, Yelena Mironchik, Chien-Fu Hung, TC Wu, Zaver M. Bhujwalla
Lin Tuo, Jin Xiang, Xuanming Pan, Qingzhu Gao, Guiji Zhang, Yi Yang, Li Liang, Jie Xia, Kai Wang, Ni Tang